PATENT CLAIM ANALYSIS

Application Number: 15744712
Application Type: Utility
Filing Date: 2018-01
Publication Date: 2018-07
Patent Classification: ["514", "016800"]

Abstract:
Provided are fusion polypeptides comprising fragments from a first and a second FGF family member, nucleic acids encoding the fusion polypeptides, vectors and host cells containing the same, and methods of making and using such compositions in the treatment of FGF-related diseases, disorders, and conditions.

Claim (Index 32):
The fusion polypeptide of  claim 22  or  23 , further comprising at least one modification in an amino acid residue corresponding to that in FGF18 (SEQ ID NO: 1), wherein said at least one modification is selected from the group consisting of Y151L, P152Y, K153Q, 156aL, 156bP, 156cF, 156dP, 156eN, 156fH, P156A, L158K, P161Q, K163E, Y164F, 165aV, 165bG, 165cS, 165dA, 165eP, T166R, V167R, 5171T, I174P, R175Q, T177L, H178T, des P179, and des A180.

Metadata:
- Claim Count in Document: 112.0
- Percentile: 86.0
- Lexical Diversity: 1.37838
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: True
- Related Applications: ['15107101', '14380277', '13515429', '15660116', '10251947']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7550002178270732
- 35 USC 102 Novelty (BERT): 0.5442173651011376
- Combined Prediction Score: 0.7339219325544796
- Mean Citation Score: 314.01251
- Max Citation Score: 411.7714
- Similarity Product: 272.7006828871489

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test